Title: BXQ-350: A novel approach to rebalancing the tumor's immune response Abstract Number: 1331 Date: Friday, November 8, 2024 Author: Gilles Tapolsky, PhD, Vice President of Pharmacology, Bexion ...

Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) An ...

That food pyramid you grew up learning about via the U.S. Dietary Guidelines is about to get a major overhaul.

Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes #469 oral presentation Session: 626.

Super heroes, witches, and menacing jack-o'-lanterns lined the tables of entries in the Cherokee County 4-H Pumpkin Fair, ...

And we say creativity is not something you are. It's not something you can be. It's something you can participate in. And if ...

Most parents probably know that their children aren’t going to be 100% open and honest with them. There are always going to ...

This fall, provinces from coast to coast confidently announced that they were banning phones in the classroom. It’s not going ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

South Whidbey Elementary is one of 7 Washington schools to receive the STEM Lighthouse School award. With forests, farmland ...

The Downtown Little Rock Partnership, Central Arkansas Library System, Plaza Frida and Mexican Consulate of Little Rock team ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...